Refinement of the GINGF3 locus for hereditary gingival fibromatosis by Pampel, Michael et al.
ORIGINAL PAPER
Refinement of the GINGF3 locus for hereditary
gingival fibromatosis
Michael Pampel & Sandra Maier & Alfons Kreczy &
Helga Weirich-Schwaiger & Gerd Utermann &
Andreas R. Janecke
Received: 26 January 2009 /Accepted: 8 July 2009 /Published online: 26 July 2009
# The Author(s) 2009. This article is published with open access at Springerlink.com
Abstract Hereditary gingival fibromatosis (HGF) is a rare,
clinically variable disorder characterized by slowly pro-
gressive fibrous overgrowth of the gingiva. Four gene loci
have been mapped for autosomal dominant non-syndromic
HGF (adHGF). The molecular basis of adHGF remains
largely unknown, with only a single SOS1 gene mutation
identified so far at the gingival fibromatosis 1 (GINGF1)
locus in one family. We identified an adHGF family with
ten affected individuals in whom onset of gingival
fibromatosis concurred with the eruption of the primary
teeth. In order to identify the molecular basis in this family,
we tested for linkage of the disease to known adHGF loci.
A maximal multipoint logarithm of the odds score of 3.91
was obtained with marker D2S390 (θ=0) at the GINGF3
locus on chromosome 2p23.3–p22.3, and linkage to other
known loci was excluded. Sequencing two candidate genes,
ALK and C2orf18, and a single nucleotide polymorphisms
array analysis did not reveal a mutation or copy number
variation in a patient from the family. We refined the
GINGF3 locus to a 6.56-cM, 8.27-Mb region containing
112 known and hypothetical genes, and our data and a
search of the literature suggest that GINGF3 is a major
adHGF locus.
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Introduction
Gingival fibromatosis (gingival hyperplasia) may result
from systemic medication with calcium-channel blockers,
cyclosporin, dilantin, and phenytoin, or it may be heredi-
tary. In severe cases, the gingival enlargement may cover
the crowns of teeth and cause severe functional and esthetic
concerns. Hereditary gingival fibromatosis (HGF) is a rare
condition that can occur as an isolated disease or as part of
a number of syndromes or chromosomal abnormalities [1,
2]. The onset of gingival overgrowth generally coincides
with the eruption of the permanent incisors, infrequently
with the eruption of the primary dentition, and it rarely
presents already at birth. Among the non-syndromic HGFs,
autosomal recessive [3] and autosomal dominant inheri-
tance have been described [2]. Linkage studies have
localized loci for autosomal dominant non-syndromic forms
of gingival fibromatosis (adHGF) to chromosomes 2p21–
p22 (GINGF1, OMIM 135300) [4, 5], 2p22.3–p23.3
(GINGF3, OMIM 609955) [6], and 5q13–q22 (GINGF2,
OMIM 605544) [7]. Delineation of chromosome 2p13–p21
duplication in a patient with HGF in association with
mental retardation and facial dysmorphism suggested
another HGF locus on chromosome 2p13–p21 [8]. Recent-
ly, an apparently maternally inherited form of gingival
fibromatosis was mapped to chromosome 11p15 in two
unrelated Chinese families [9]. The molecular basis of HGF
M. Pampel
Coburg, Germany
S. Maier:H. Weirich-Schwaiger:G. Utermann:
A. R. Janecke (*)
Division of Clinical Genetics, Innsbruck Medical University,
Schoepfstrasse 41,
6020 Innsbruck, Austria
e-mail: Andreas.Janecke@i-med.ac.at
A. Kreczy
Institute of Pathology, Hospital Coburg,
Coburg, Germany
Eur J Pediatr (2010) 169:327–332
DOI 10.1007/s00431-009-1034-9remains largely unknown. One mutation in the SOS1 (son
of sevenless one) gene (OMIM 182530) has been identified
at the GINGF1 locus in a single adHGF family. Diagnosis
of HGF is based on medical history and clinical examina-
tion, since there are currently no specific immunohisto-
chemical markers available.
Materials and methods
We ascertained a German four-generation family with
autosomal dominant transmission of HGF without evidence
for parental imprinting through a proband. Fifteen family
members were examined and nine (five male and four
female) were classified as affected (Fig. 1, individuals
12170, 3, 11284, 13230, 11602, 12163, 13232, 11603, and
11606) based on the following criteria: enlarged gingiva
covering at least one third of clinical dental crowns of five
or more teeth and lack of exposure of affected members to
any inducible drugs; individuals were otherwise healthy.
The deceased male founder of this family (Fig. 1, individual
1 )w a sr e p o r t e da sh a v i n gb e e na f f e c t e db yH G F .F i v e
spouses of family members were also examined, and samples
were taken for molecular investigation (individuals 12021,
11378, 13231, 11253, and 11760 in Fig. 1). No samples were
available from individuals 1–6s h o w ni nF i g .1, and their
genotypes were inferred and haplotypes were re-constructed
(see below).
Informed consent was obtained from all participants
following genetic counseling. DNA was extracted from
peripheral blood samples, from paraffin-embedded tissue
sections, and from buccal smears, and RNA was extracted
from cultured fibroblasts using an automated extractor
according to the manufacturer's protocols (GenoM 48,
Qiagen, Vienna, Austria). For linkage analysis, highly
polymorphic microsatellite markers were selected from
2p21–p23.3 and from 5q13–q22 (http://www.gdb.org/).
Locus order and sex-averaged inter-marker distances were
taken from the Marshfield map (http://research.marshfield
clinic.org/genetics/). Marker alleles were detected by electro-
phoresing the PCR products on 6% polyacrylamide gels
followed by silver staining. We used the Allegro program
[10] to compute haplotypes as well as two-point and
multipoint logarithm of the odds (LOD) scores, under the
assumption of autosomal dominant inheritance with 100%
penetrance, and with the disease-allele frequency set at.0001,
and equal marker allele frequencies. A whole-genome
analysis of copy number variation was conducted in one
patient (12170, Fig. 1) using the Affymetrix Genome-Wide
Human SNP 6.0 array according to the specifications of the
manufacturer. Oligonucleotide primer sequences and con-
ditions to sequence the ALK and C2orf18 genes in
complementary DNA (cDNA) are available on request.
Results
Remarkably, the onset of gingival fibromatosis consistently
concurred with the eruption of the primary teeth in all
affected members of this family. Gingival fibromatosis
developed slowly progressive and variably consisted of
localized or generalized enlargement of keratinized gingiva
and consisted of dense fibrous tissue that feels firm and
nodular on palpation (Fig. 2a–d). Gingival excess tissue
resulted in periodontal problems. Difficulties in daily oral
hygiene and long-term smoking were recorded in patients
with most severe findings (Fig. 2c, d). Histological
evaluation of specimens from different individuals of the
family showed hyperplasia of fibrous tissue characterized
by squamous epithelium with elongated rete ridges over-
laying dramatically increased cell poor fibrous tissue
(Fig. 3). A pseudoepitheliomatous hyperplasia of the
squamous epithelium with formation of papillae was seen
in severely affected individuals.
Haplotype and LOD score analyses excluded GINGF1
(Figs. 1 and 4 and Table 1) and GINGF2 (data not shown)
in this adHGF family. Linkage of the disease to GINGF3
was demonstrated with a maximal two-point LOD score of
3.45 with marker D2S171 (θ=0; Table 1) and a maximal
multipoint LOD score of 3.91 with marker D2S390 (θ=0;
Fig. 4). Recombinations defined markers D2S220 and
D2S352 as boundaries of the linked interval (Fig. 1). The
candidate region defined in the presented family overlaps
with the 11.42-cM, 13.04-Mb GINGF3 interval flanked by
marker loci D2S2221 and D2S1788, originally defined in
one Chinese family [6] .A c c o r d i n gt ot h ec u r r e n tN C B I
draft sequence of the human genome, build 36.3, the
original and the refined GINGF3 candidate region
contain 131 and 112 known and hypothetical genes.
Prioritarization of candidate genes for mutation analysis
considers expression in gingival or connective tissue and a
putative function of the gene product in cell cycle control
or extracellular matrix composition. Three interactive,
web-based implementations, SUSPECTS (http://www.
genetics.med.ed.ac.uk/suspects/), GeneWanderer (http://
compbio.charite.de/genewanderer/GeneWanderer), and
GeneDistiller (http://www.genedisteller.org)[ 11]w e r e
queried in addition to a manual approach to identify the
disease gene based on expression and functional data
contained in the NCBI database (http://www.ncbi.nlm.nih.
gov/sites/gene). However, sequencing two candidate
genes, ALK, encoding a receptor protein–tyrosine kinase
and C2orf18 encoding an adenine nucleotide translocase 2
binding protein in cDNA from fibroblasts did not reveal a
mutation in a patient from the presented family. A whole-
genome analysis of copy number variation in the same
patient detected neither aberrations at the GINGF3 locus
nor elsewhere.
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The candidate region defined in the presented family
overlaps with the GINGF3 interval originally defined in
one Chinese family [6]. Under the hypothesis that this locus
contains a single HGF gene, we refined it to a 6.56-cM,
8.28-Mb interval flanked by maker loci D2S2221 and
D2S352 (Figs. 1, 4) and confirm the presence of an
additional HGF gene on chromosome 2p distinct from the
GINGF1 locus. The data of at least five published smaller
Fig. 1 Pedigree and haplotypes of the HGF family under study. The
proband, indicated by an arrow, has two affected and two unaffected
children with four different partners. Haplotype analysis excluded the
SOS1 gene at the GINGF1 locus as the disease gene in this family and
narrowed the original 11.42-cM, 13.04-Mb GINGF3 locus, flanked by
marker loci D2S2221 and D2S1788, down to the region between
markers D2S220 and D2S352
Eur J Pediatr (2010) 169:327–332 329adHGF families are compatible with linkage to this locus
[5, 6]. These previous reports and our data suggest that
GINGF3 is a major adHGF locus.
Previous studies on HGF suggest a function of the
GINGF3 gene product in cell cycle control, and more
specifically, the gene product might directly or indirectly
interact with SOS1. A heterozygous SOS1 single base
insertion leading to a C-terminally truncated protein,
leading to sustained activation of RAS/MAPK signaling
in fibroblasts, was identified in the form of HGF [12, 13].
Mutations in another component of the RAS/MAPK
pathway, HRAS, can cause Costello syndrome, a
malformation-dysmorphism syndrome with gingival hyper-
trophy as a feature [14]. Most recently, dysregulation of the
human mitogen-activated protein kinase kinase 6
(MAP2K6) was implicated in the pathogenesis of a
syndromic form of HGF, congenital generalized hyper-
trichosis terminalis [15]. Therefore, genes from the candi-
Fig. 2 Gingival overgrowth in
a a 6-year-old female and b 13-
year-old male showing symmet-
rical gingival hyperplasia.
c Severe involvement in a male
at age 36 years and d a female
proband aged 37 years, 7 years
after last surgical intervention
Fig. 3 Histopathological
findings in two individuals from
the presented family. a Squa-
mous epithelium with elongated
rete ridges overlaying dramati-
cally increased cell poor fibrous
tissue (original magnification,
×100, H&E stain). b Pseudoe-
pitheliomatous hyperplasia of
the squamous epithelium with
formation of papillae in individ-
uals with marked inflammatory
infiltrates (original magnifica-
tion, ×100, H&E stain)
330 Eur J Pediatr (2010) 169:327–332date region encoding for components of the RAS/MAPK
pathway will be given priority regarding sequence analysis
to identify the mutation causing HGF in the presented
family. For example, RAB10 from the interval encodes a
member of the RAS (see HRAS; OMIM 190020) super-
family of small GTPases. RAB proteins localize to exocytic
and endocytic compartments and regulate intracellular
vesicle trafficking; however, the particular function of
RAB10 is unknown. Most genes from the candidate region
are incompletely characterized such as GPN1, which
encodes a guanosine triphosphatase enzyme that may play
a role in DNA repair and may function in activation of
transcription, and AGBL5, a putative ATP/GTP binding
protein. CIB4, encoding calcium and integrin binding
family member 4, may represent a further HGF candidate
gene considering that calcium channel blockers can induce
gingival hyperplasia. Candidates further include PPP1CB,
encoding one of the three catalytic subunits of protein
phosphatase 1, which is known to be involved in the
regulation of cell division, glycogen metabolism, muscle
Table 1 Two-point linkage analysis between the HGF locus and chromosome 2p markers
Marker Genetic LOD score at θ Zmax θmax
Distance (cM) 0.00 0.01 0.05 0.10 0.20 0.30 0.40
D2S320 38.33 −∞ 1.04 1.53 1.58 1.44 1.22 1.01 1.58 0.09
D2S2233 39.93 −∞ 0.78 1.29 1.36 1.24 1.06 0.87 1.36 0.10
D2S2342 40.47 0.95 0.93 0.84 0.74 0.56 0.41 0.29 0.95 0
D2S220 42.65 −0.69 1.26 1.76 1.82 1.67 1.44 1.22 1.82 0.09
D2S2201
a 41.57 1.83 1.79 1.64 1.45 1.13 0.87 0.66 1.83 0
D2S2221 44.09 2.19 2.15 1.99 1.80 1.46 1.16 0.92 2.19 0
D2S171 45.30 3.45 3.39 3.16 2.89 2.40 1.97 1.60 3.45 0
D2S144 45.30 3.42 3.36 3.13 2.86 2.37 1.95 1.59 3.42 0
D2S365 47.97 0.95 0.93 0.85 0.75 0.58 0.44 0.33 0.95 0
D2S390 48.50 3.31 3.25 3.03 2.77 2.30 1.89 1.54 3.31 0
D2S352 50.65 −∞ −1.51 −0.29 0.11 0.33 0.35 0.32 0.36 0.27
D2S2347 50.65 −∞ −0.34 0.24 0.40 0.45 0.42 0.37 0.45 0.19
D2S367 54.96 0.95 0.93 0.88 0.82 0.69 0.59 0.49 0.95 0
D2S1788 55.51 −∞ −0.92 0.27 0.62 0.76 0.71 0.61 0.76 0.20
D2S2163 59.36 −∞ −0.61 −0.02 0.15 0.23 0.22 0.19 0.23 0.23
D2S177 59.36 −∞ −4.01 −2.05 −1.32 −0.71 −0.43 −0.28 −0.28 0.40
D2S2238 60.45 −∞ −2.49 −1.20 −0.73 −0.36 −0.21 −0.13 −0.13 0.40
aThe physical map of chromosome 2 (NCBI draft sequence of the human genome, build 36.3) indicates that D2S2201 localizes centromeric to
D2S220, contrasting with the Marshfield genetic map of chromosome 2.
Fig. 4 Multipoint LOD score.
The order of analyzed markers
on chromosome 2p is shown on
the X-axis, and distances are
given in centiMorgan. The Y-
axis refers to the LOD score
Eur J Pediatr (2010) 169:327–332 331contractility, protein synthesis, and HIV-1 viral transcrip-
tion, and the protein encoded by FKBP1B, a member of the
immunophilin protein family, which play a role in immu-
noregulation and basic cellular processes involving protein
folding and trafficking. FKBP1B is a cis-trans prolyl
isomerase that binds the immunosuppressant FK506
(Tacrolimus), which can induce gingival overgrowth as a
side-effect in treated patients [16, 17].
There are clinical and histological differences in the
presented family as compared with SOS1-related gingival
fibromatosis, which might reflect the different molecular
causes of the disease. As frequently seen in HGF, an overall
cell poor increase in gingival tissue with scarce blood
vessels and islets with dense fibroblasts comparable to the
findings in the Chinese family originally defining the
GINGF3 locus [6] was noted in our patients contrasting
with SOS1-related gingival fibromatosis, which features a
higher increase in the number of fibroblasts compared with
the increase in extracellular matrix [18]. The family
presented here is also remarkable in that all patients
consistently had an early onset of the disease, at the time
of eruption of the primary teeth, also similar to the original
Chinese GINGF3 family [6], together arguing for a clinically
recognizable subtype of adHGF linked to GINGF3.
Identification of the genetic mutations involved in HGF
would provide novel aids for disease diagnosis, uncover
targets for novel treatment modalities, and improve our
understanding of the molecular mechanisms underlying
HGF and other fibrotic processes.
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